Mesenteritis

Last updated: 25 August 2026
Reviewed by: Specialist doctors from the Elfcare quality team

Chronic or recurrent abdominal pain that's difficult to localise precisely, along with nausea, bloating, or changes in bowel habits with no clear explanation, can be a sign of mesenteritis. So can unexplained weight loss, persistent fatigue, or a feeling of abdominal fullness that comes and goes over months. Mesenteritis is an inflammatory condition affecting the mesentery, the tissue that anchors the intestines to the abdominal wall and carries their blood supply.

Mesenteritis is frequently identified as an incidental finding on abdominal MRI, often in people who have been experiencing vague abdominal symptoms for years without a structural diagnosis. It is one of the less well-known abdominal conditions but clinically important to identify, both because it explains chronic symptoms and because it must be distinguished from more serious conditions including lymphoma and mesenteric metastases that can produce an identical appearance on imaging.

Book a consultation now to test your health

What is mesenteritis?

The mesentery is a continuous fold of peritoneal tissue that attaches the small intestine and parts of the large intestine to the posterior abdominal wall. It contains blood vessels, lymphatics, lymph nodes, and fatty tissue that supply and support the intestines. Mesenteritis refers to inflammation of the mesenteric fat and lymphoid tissue, causing a spectrum of pathological changes ranging from mild fatty infiltration to dense fibrosis.

Mesenteritis is classified along a spectrum of related conditions that likely represent different stages or intensities of the same inflammatory process:

  • Mesenteric panniculitis is the mildest and most common form, characterised by non-specific inflammation and fatty degeneration of the mesenteric fat. It is frequently an incidental finding on imaging with no or minimal symptoms.

  • Mesenteric lipodystrophy is characterised by replacement of mesenteric fat with lipid-laden macrophages and mild inflammation, representing an early stage of the spectrum.

  • Sclerosing mesenteritis is the most severe form, characterised by fibrosis and scarring of the mesentery that can cause bowel obstruction, mesenteric ischaemia, and significant abdominal symptoms. It is the least common but most clinically significant form.

The umbrella term retractile mesenteritis is sometimes used for the fibrotic end of the spectrum. On imaging, mesenteritis typically appears as a soft tissue mass or haziness in the mesenteric fat surrounding the superior mesenteric artery, often with a characteristic fat halo sign and a white rim sign around affected mesenteric vessels.

Symptoms of mesenteritis

Many cases of mesenteritis, particularly mesenteric panniculitis, cause no symptoms and are discovered entirely incidentally on abdominal imaging. When symptoms occur they reflect mesenteric inflammation and, in more severe cases, its mechanical consequences:

  • Chronic or recurrent abdominal pain, often diffuse or periumbilical, varying in intensity

  • Nausea and vomiting

  • Bloating and abdominal distension

  • Changes in bowel habits including diarrhoea or constipation

  • Unexplained weight loss in more significant cases

  • A palpable abdominal mass in sclerosing mesenteritis when fibrosis is extensive

  • Fever in acute inflammatory phases

  • In severe sclerosing mesenteritis: signs of bowel obstruction or mesenteric ischaemia from vascular compression

What causes mesenteritis?

The exact cause of mesenteritis is not fully understood in most cases. Contributing factors include:

  • Autoimmune mechanisms are the most widely accepted primary cause, with mesenteritis thought to represent a localised autoimmune inflammatory response within mesenteric tissue. It is associated with IgG4-related disease in a proportion of cases.

  • Previous abdominal surgery or trauma can trigger mesenteric inflammation through disruption of mesenteric tissue and subsequent repair response.

  • Infection abdominal infections including mesenteric adenitis from bacterial or viral pathogens can initiate a persistent inflammatory response in the mesentery.

  • Malignancy association mesenteritis is associated with various malignancies including lymphoma, carcinoid tumours, and other abdominal cancers in a proportion of cases. This association makes it essential to exclude malignancy when mesenteritis is identified on imaging.

  • Paraneoplastic mechanism some cases of mesenteritis may represent a paraneoplastic immune response to an occult malignancy.

  • Autoimmune conditions including inflammatory bowel disease and rheumatoid arthritis are associated with mesenteric inflammatory changes.

  • Idiopathic the majority of cases have no clearly identifiable cause.

How is mesenteritis detected?

Mesenteritis is detected primarily through abdominal imaging, with blood tests identifying inflammatory and systemic conditions associated with its development and excluding malignancy.

Abdominal MRI Elfcare’s full-body MRI maps the mesentery and identifies inflammation as part of routine imaging, adding complementary soft-tissue detail that can help distinguish harmless inflammation from conditions like lymphoma, though a tissue biopsy is sometimes still needed for a definitive diagnosis.

Blood tests identify systemic inflammatory conditions associated with mesenteritis and raise or lower suspicion for malignancy as an underlying or associated cause. Relevant markers in Elfcare's panel include:

  • CRP reflects systemic inflammation associated with active mesenteritis and helps assess disease activity and treatment response

  • Full blood count and differential lymphocytosis or other white cell abnormalities raise suspicion for lymphoma as an alternative or associated diagnosis

  • Albumin low albumin from malnutrition or significant inflammatory disease reflects the systemic impact of severe mesenteritis

  • Ferritin markedly elevated ferritin raises suspicion for haematological malignancy or significant systemic inflammatory disease

  • HbA1c and glucose metabolic health context relevant to the overall clinical assessment

  • RF screen for autoimmune conditions including rheumatoid arthritis associated with mesenteric inflammation

  • ALP and bilirubin assess for biliary involvement from mesenteric fibrosis compressing bile duct structures in sclerosing mesenteritis

Why early detection matters

Mesenteric panniculitis identified early, when it represents mild inflammatory change rather than established fibrosis, can be monitored and managed conservatively before progression to sclerosing mesenteritis with its more serious mechanical consequences. Identifying mesenteritis also prompts a systematic search for associated malignancy, particularly lymphoma, which is present in a clinically important proportion of cases and which requires very different management. For patients in whom mesenteritis is the structural explanation for years of unexplained abdominal pain, an accurate diagnosis ends a diagnostic odyssey, enables appropriate treatment, and prevents unnecessary investigations for other causes.

How Elfcare can help

Elfcare's full body MRI images the mesentery directly as part of the standard abdominal sequence, identifying the characteristic findings of mesenteritis and providing the soft tissue characterisation needed to distinguish it from lymphoma and mesenteric malignancy. For a condition that is frequently the structural explanation for years of unexplained abdominal symptoms, this imaging assessment provides both the diagnosis and the basis for appropriate management.

Our blood panel covers CRP, full blood count, albumin, ferritin, and liver function, identifying the inflammatory and systemic markers most relevant to mesenteritis assessment and raising suspicion for associated malignancy when the pattern of results warrants it.

If our MRI or blood tests identify mesenteritis or related mesenteric findings, we take care of further diagnostics or refer you to the appropriate specialist.

Book a consultation to learn more

Summary

Mesenteritis is an inflammatory condition of the mesenteric fat and lymphoid tissue ranging from mild incidental panniculitis to severe sclerosing disease causing bowel obstruction and mesenteric ischaemia. It is frequently discovered incidentally on abdominal MRI and must be distinguished from lymphoma and mesenteric malignancy that can produce identical imaging appearances. Elfcare's full body MRI images the mesentery directly, characterising inflammatory changes and identifying features that distinguish mesenteritis from malignancy, while our blood panel covers inflammatory markers and haematological findings relevant to both diagnoses. Early identification provides a structural explanation for chronic abdominal symptoms, prompts appropriate malignancy exclusion, and enables treatment before progressive fibrosis causes irreversible mechanical complications.

Last updated: 25 August 2026
Reviewed by: Specialist doctors from the quality team at Elfcare

FAQ

  • Mesenteritis is inflammation of the mesentery, the tissue connecting the intestines to the abdominal wall. It ranges from mild mesenteric panniculitis, a common incidental imaging finding, to sclerosing mesenteritis with progressive fibrosis causing bowel obstruction. It is most commonly discovered incidentally on abdominal MRI and must be distinguished from lymphoma and mesenteric metastases that can produce similar imaging appearances.

  • Chronic or recurrent diffuse abdominal pain, nausea, bloating, changes in bowel habits, and unexplained weight loss. Many cases of mesenteric panniculitis cause no symptoms at all. Severe sclerosing mesenteritis causes bowel obstruction symptoms including severe abdominal pain, vomiting, and distension.

  • The exact cause is not fully understood in most cases. Autoimmune mechanisms, previous abdominal surgery or infection, association with malignancy including lymphoma, IgG4-related disease, and inflammatory bowel disease are contributing factors. The majority of cases are idiopathic without a clearly identifiable trigger.

  • Abdominal MRI is the primary detection tool, directly imaging the mesentery and identifying characteristic findings including the fat halo sign and white rim sign that distinguish mesenteritis from malignancy. Blood tests covering CRP, full blood count, LDH, and albumin assess inflammatory activity and raise or lower suspicion for associated malignancy.

  • Yes. Elfcare's full body MRI images the mesentery directly as part of the standard abdominal sequence, identifying inflammatory changes and distinguishing mesenteritis from lymphoma and mesenteric malignancy. Our blood panel covers CRP, full blood count, albumin, and ferritin. If mesenteritis or related findings are identified, we take care of further diagnostics or refer you to the appropriate specialist.

  • Yes. Mild mesenteric panniculitis often requires no treatment beyond monitoring with interval imaging to confirm stability. Symptomatic cases are treated with corticosteroids, which reduce inflammation effectively in most patients. Tamoxifen and colchicine are used in sclerosing mesenteritis to reduce fibrosis progression. Surgical intervention may be required for bowel obstruction from severe sclerosing disease. Treating any associated underlying condition including malignancy or autoimmune disease is the most important intervention when an associated cause is identified. Early treatment before significant fibrosis has developed consistently produces the best long-term outcomes.